137 related articles for article (PubMed ID: 27208626)
1. The UVB1 Vitamin D analogue inhibits colorectal carcinoma progression.
Ferronato MJ; Alonso EN; Gandini NA; Fermento ME; Villegas ME; Quevedo MA; Arévalo J; López Romero A; Rivadulla ML; Gómez G; Fall Y; Facchinetti MM; Curino AC
J Steroid Biochem Mol Biol; 2016 Oct; 163():193-205. PubMed ID: 27208626
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
3. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
Larriba MJ; Martín-Villar E; García JM; Pereira F; Peña C; de Herreros AG; Bonilla F; Muñoz A
Carcinogenesis; 2009 Aug; 30(8):1459-68. PubMed ID: 19502595
[TBL] [Abstract][Full Text] [Related]
4. Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.
Taghizadeh F; Tang MJ; Tai IT
Mol Cancer Ther; 2007 Jan; 6(1):309-17. PubMed ID: 17237289
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D analogues exhibit antineoplastic activity in breast cancer patient-derived xenograft cells.
Ferronato MJ; Nadal Serrano M; Arenas Lahuerta EJ; Bernadó Morales C; Paolillo G; Martinez-Sabadell Aliguer A; Santalla H; Mascaró M; Vitale C; Fall Y; Arribas J; Facchinetti MM; Curino AC
J Steroid Biochem Mol Biol; 2021 Apr; 208():105735. PubMed ID: 32784045
[TBL] [Abstract][Full Text] [Related]
6. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
[TBL] [Abstract][Full Text] [Related]
7. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
8. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
9. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D analogue: potent antiproliferative effects on cancer cell lines and lack of hypercalcemic activity.
Ferronato MJ; Salomón DG; Fermento ME; Gandini NA; López Romero A; Rivadulla ML; Pérez-García X; Gómez G; Pérez M; Fall Y; Facchinetti MM; Curino AC
Arch Pharm (Weinheim); 2015 May; 348(5):315-29. PubMed ID: 25864390
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin.
Zhang XL; Chen ML; Zhou SL
Int J Clin Exp Pathol; 2015; 8(1):227-35. PubMed ID: 25755709
[TBL] [Abstract][Full Text] [Related]
12. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model.
Moore RG; Lange TS; Robinson K; Kim KK; Uzun A; Horan TC; Kawar N; Yano N; Chu SR; Mao Q; Brard L; DePaepe ME; Padbury JF; Arnold LA; Brodsky A; Shen TL; Singh RK
PLoS One; 2012; 7(4):e34443. PubMed ID: 22509304
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of all A-ring stereoisomers of 5,6-trans-2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: possible binding modes of potent A-ring analogues to vitamin D receptor.
Fujishima T; Konno K; Nakagawa K; Tanaka M; Okano T; Kurihara M; Miyata N; Takayama H
Chem Biol; 2001 Nov; 8(11):1011-24. PubMed ID: 11731293
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells.
Kouchi Z; Fujiwara Y; Yamaguchi H; Nakamura Y; Fukami K
Biochem Biophys Res Commun; 2011 May; 408(4):523-9. PubMed ID: 21514270
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway.
Wang W; Zhao CH; Zhang N; Wang J
Nutr Cancer; 2013; 65(7):1067-75. PubMed ID: 24099173
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
